The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: A literature investigation

Rheumatology

Volumn 41, Issue 6, 2002, Pages 619-630

  Jennekens, F G I ^a   Kater, L ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE   (Netherlands)

Author keywords

Central nervous system syndromes; Nomenclature; Pathogenesis; Systemic lupus erythematosus

Indexed keywords

MYELIN; PHOSPHOLIPID ANTIBODY; PROTEIN ANTIBODY; RIBOSOME PROTEIN;

ARTERY OCCLUSION; ATHEROSCLEROSIS; BRAIN DEGENERATION; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INJURY; CELL VACUOLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; ISCHEMIA; LEUKOENCEPHALOPATHY; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; NERVE CELL; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PUBLICATION; REVIEW; SPINAL CORD HEMORRHAGE; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; VEIN OCCLUSION; WHITE MATTER;

BRAIN ISCHEMIA; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; TERMINOLOGY; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 0036270245     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (137)

1. The central nervous system in systemic lupus erythematosus. Clinical syndromes: A literature investigation
2. The 1982 revised criteria for the classification of systemic lupus erythematosus
3. Updating the American College of Rheumatology Criteria for the Classification of Systemic Lupus erythematosus
4. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus
5. Antiphospholipid antibodies and thrombosis
6. Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus
7. Chorea in systemic lupus erythematosus and 'lupus-like' disease: Association with antiphospholipid antibodies
8. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus
9. Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients
10. Large cerebral vessel occlusive disease in systemic lupus erythematosus
11. Transverse myelitis: A manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies
12. Acute transverse myelopathy in systemic lupus erythematosus
13. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus
14. Lupus anticoagulant as a prognostic marker in systemic lupus erythematosus
15. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients
16. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus-a meta-analysis
17. Epidemiology of the antiphospholipid antibody syndrome
18. Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: Prevalence, recognition by patients and preventive practices
19. Differential diagnosis of the central nervous system manifestations of the antiphospholipid syndrome
20. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis
21. Anticardiolipin antibodies are not an independent risk factor for stroke. An incident case-referent study nested within the MONICA and Västerbotten Cohort Project
22. Antibodies against cardiolipin and oxidatively modified LDL in 50-year old men predict myocardial infarction
23. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the Italian registry
24. IgG anticardiolipin antibody titer >40 GPL and the risk of subsequent thrombo-occlusive events and death: A prospective cohort study
25. Anticardiolipin antibodies in an unselected stroke population
26. Anticardiolipin antibodies and their associations with cerebrovascular risk factors
27. Prevalence of anti-protein S antibodies in patients with systemic lupus erythematosus
28. Premature atherosclerosis in systemic lupus erythematosus
29. Systemic lupus erythematosus: A model for atherogenesis?
30. Athero-sclerosis-an inflammatory disease
31. Age specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study
32. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus
33. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus
34. Frequency, etiology and prevention of stroke in patients with systemic lupus erythematosus
35. Stroke in systemic lupus erythematosus
36. Chylomicron metabolism is markedly altered in systemic lupus erythematosus
37. Atheroma: Links with antiphospholipid antibodies, Hughes syndrome and lupus
38. Adoptive transfer of beta (2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice
39. Lipoprotein (a) levels in systemic lupus erythematosus
40. Premature cardiovascular disease in chronic renal failure
41. The neurological manifestations of systemic lupus erythematosus: A clinicopathological study of 24 cases and review of the literature
42. Clinical and neuropathological findings in systemic lupus erythematosus: The role of vasculitis, heart emboli and thrombotic thrombocytopenic purpura
43. Brain pathology in systemic lupus erythematosus
44. Lupus-related myelopathy: Report of three cases and review of the literature
45. Thrombotic cerebral arteriopathy in patients with the antiphospholipid syndrome
46. Magnetic resonance imaging of the brain in systemic lupus erythematosus
47. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus
48. Neuroimaging in neuropsychiatric systemic lupus erythematosus
49. The significance of cerebral white matter abnormalities: 100 years after Binswanger's report. A review
50. Pathogenesis of leukoaraiosis: A review
51. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus
52. Cognitive impairment in patients with systemic lupus erythematosus
53. White matters: Small vessels and slow thinking in old age
54. Cerebral white matter lesions and cognitive function: The Rotterdam Scan Study
55. Central nervous system systemic lupus erythematosus mimicking progressive multifocal leucoencephalopathy
56. Neurologic manifestations of pediatric systemic lupus erythematosus
57. Cerebral vein thrombosis in childhood systemic lupus erythematosus
58. Cerebral venous thrombosis and acquired protein S deficiency: An uncommon cause of headache in systemic lupus erythematosus
59. Dural sinus thrombosis: A mechanism for pseudotumor cerebri in systemic lupus erythematosus
60. Cerebral venous thrombosis in systemic lupus erythematosus
61. Is pseudotumor cerebri in SLE a thrombotic event?
62. Pseudotumor cerebri in systemic lupus erythematosus
63. Pseudotumor cerebri associated with cerebral venous thrombosis, internal jugular vein thrombosis and systemic lupus erythematosus
64. Patients with antiphospholipid antibodies: CT and MRI findings of the brain
65. Cerebral venous thrombosis and anticardiolipin antibodies
66. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus
67. Embolic stroke complicating systemic lupus erythematosus
68. Aortic root thrombus causing stroke in a patient with lupus erythematosus
69. Dissections and trauma of cervicobrachial arteries
70. Three cases of spontaneous extracranial vertebral artery dissection
71. Vertebrobasilar artery territory infarction as an initial manifestation of systemic lupus erythematosus
72. Granulomatous cerebral vasculitis in systemic lupus erythematosus during systemic remission of disease
73. Cerebellum and brainstem vasculopathy in systemic lupus erythematosus: Two clinico-pathological cases
74. Severe cerebral and systemic necrotizing vasculitis developing during pregnancy in a case of systemic lupus erythematosus
75. Large intracranial arteritis with giant cells in systemic lupus erythematosus
76. Florid central nervous system vasculitis in a fatal case of systemic lupus erythematosus
77. Cerebral transmural angiitis and ruptured aneurysm: A complication of systemic lupus erythematosus
78. Large vessel vasculitis of the central nervous system in systemic lupus erythematosus: Report and review of the literature
79. MRI and angiographic diagnosis of lupus cerebral vasculitis
80. Changes in regional cerebral blood flow after a cold hand test in systemic lupus erythematosus
81. Vascular events in hypertensive patients with systemic lupus erythematosus
82. Subarachnoid hemorrhage and systemic lupus erythematosus
83. Cerebral berry aneurysms and systemic lupus erythematosus
84. Distal superior cerebellar artery aneurysm in a patient with systemic lupus erythematosus: Case report
85. Subarachnoid haemorrhage: Diagnosis, causes and management
86. Coexistence of coronary aneurysms and total occlusion of coronary arteries in systemic lupus erythematosus
87. Association of aortic aneurysm in patients with systemic lupus erythematosus: A series of case reports and a review of the literature
88. Systemic lupus erythematosus presenting with neurological disorders
89. Lupoid sclerosis with antiphospholipid and antimyelin antibodies
90. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus
91. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature
92. Systemic lupus erythematosus with multiple perivascular spongy changes in cerebral deep structures, midbrain, and cerebellar white matter. A case report
93. Disseminated perivenous necrotizing encephalomyelitis in systemic lupus erythematosus: Report of an autopsy case
94. Peripheral white matter lesions of the spinal cord with changes in small arachnoid arteries in systemic lupus erythematosus
95. Transverse myelopathy in systemic lupus erythematosus: An analyses of 14 cases and review of the literature
96. Devic's neuromyelitis optica: A clinicopathological study of 8 patients
97. MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica
98. The clinical course of neuromyelitis optica (Devic's syndrome)
99. Matrix metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica
100. MR of vasculitis-induced optic neuropathy
101. A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus. Clinicopathologic report and review of the literature
102. Lupus-related myelitis: Serial MR findings
103. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms
104. Longitudinal involvement of the entire spinal cord and medulla oblongata in acute catastrophic onset transverse myelitis in SLE
105. Dementia with leukoencephalopathy in systemic lupus erythematosus
106. Systemic lupus erythematosus presenting with diffuse low density lesions in the cerebral white matter on computed axial tomography scans: Its implication in the pathogenesis of diffuse central nervous system lupus
107. Diffuse central nervous system lupus involving white matter, basal ganglia, thalami and brainstem
108. Pseudotumor cerebri and leukoencephalopathy in childhood lupus
109. Unusual neuroradiological findings in systemic lupus erythematosus
110. A reversible posterior leukoencephalopathy syndrome
111. Hypertensive emergencies
112. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus
113. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor
114. CRMP-5 neuronal antibody: Marker of lung cancer and thymoma-related autoimmunity
115. Diagnostic and statistical manual of mental disorders (DSM IV)
116. Lymphocyte and neuronal antigens in neuropsychiatric lupus: Presence of an elutable, immunoprecipitable lymphocyte/neuronal 52 kd reactivity
117. A neuropathological study of a case of lupus erythematosus with chorea
118. Abnormal antidiuretic hormone secretion in patients with systemic lupus erythematosus
119. Neuropsychiatric systemic lupus erythematosus and the syndrome of inappropriate secretion of antidiuretic hormone: A case report with very late onset systemic lupus erythematosus
120. Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein
121. Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal
122. Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus. Combination with anticardiolipin antibody assay and magnetic resonance imaging
123. Immunology of the antiphospholipid syndrome
124. Ultrastructural localization of monoclonal antiphospholipid antibody binding to rat brain
125. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus
126. A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythematosus
127. Neurology of the inflammatory connective tissue diseases
128. Coping with chronic physical illness
129. Psychological changes with normal aging
130. Mood disorders: Introduction and overview
131. Anxiety disorders: Clinical features
132. Cross-sectional and longitudinal analysis of coping responses and health status in persons with systemic lupus erythematosus
133. Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: Do the benefits outweigh the risks? A decision analysis
134. Primary prevention of thrombosis in subjects with positive antiphospholipid antibodies
135. Intra-arterial thrombolysis in acute stroke
136. Cerebral venous thrombosis: Nothing, heparin, or local thrombolysis?
137. Do we know which patients with the antiphospholipid syndrome should receive long-term high dose anticoagulation?